Sun Pharmaceutical Industries Limited — Updates, 20-06-2026: General Updates
20-06-2026 | 05:23 pm
20-06-2026 | 05:23 pm
Sun Pharma acquired 100% of Innovcare Lifesciences for ~Rs 271.2 Cr cash, bolstering its product portfolio in pharmaceuticals, nutraceuticals, and cosmeceuticals. Innovcare reported FY26 revenue of Rs 94.06 Cr.
No comments yet. Be the first to comment!
All announcements from Sun Pharmaceutical Industries Limited
